91026 Results
Article
More than a dozen countries worldwide have suspended the Oxford-AstraZeneca COVID-19 vaccine distribution amid reports of exceedingly rare, yet potentially dangerous, blood clots or low platelet counts developed by a small percentage of vaccine recipients.